Beetroot juice is one of the most powerful natural medicines, with long tradition in the international folklore. Beetroot has demonstrated excellent results in the recovery of cancer patients, especially when it came to the leukemia patients.
Beetroot contains betaine and amino acids that have natural anti-cancer properties. Moreover, this plant has anti-inflammatory, antioxidant and detoxifying properties that are essential when treating cancer and recovering from diseases.
The studies have shown that betaine – the active ingredient in the beetroot – attacks the cancer cells found in the body tissues. The pigments in this plant are known as betacyanins and they are also powerful anti-cancer agents that fight against colon and breast cancer and other serious conditions. According to statistics, most cancer patients respond well to beetroot juice therapy.
Beetroot Juice Treatment
Beetroot juice therapy against leukemia and tumors is extremely simple. The cancer patients must consume 500 ml of beetroot juice per day; this means about 2 glasses of juice. The best time of the day to consume this beverage is in the morning, on an empty stomach, or 1 hour after breakfast. Other researchers mention that people should take 900 grams of beetroot per day. It can be consumed grated, in salads or as juice.
The best results were seen when the patients have started the beetroot treatment in the early stages of cancer, slowly increasing the daily dose. Despite this, a recent study conducted on patients suffering of advanced and inoperable cancer has shown that the daily consumption of 230 ml of beetroot juice for 3 – 4 months has significantly improved their health. Moreover, their immune system has become stronger.
Since not everyone likes the beetroot juice taste, it can be combined with apple juice or carrot juice. You can even add a little bit of honey to your juice.
Before starting a beetroot juice treatment, you must consult your doctor to establish the appropriate dosage for your condition. The specialist will also be able to monitor the disease evolution and the effects of the treatment.